Bio Veda Technologies Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 07-07-2024
- Paid Up Capital ₹ 0.20 M
as on 07-07-2024
- Company Age 24 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -32.26%
(FY 2020)
- Profit -33.08%
(FY 2020)
- Ebitda -272.46%
(FY 2020)
- Net Worth 3.03%
(FY 2020)
- Total Assets 2.53%
(FY 2020)
About Bio Veda Technologies
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Vinita Jain and Ishaan Jain serve as directors at the Company.
- CIN/LLPIN
U24233AS2000PTC006234
- Company No.
006234
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jul 2000
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Shillong
Industry
Company Details
- Location
Kamrup, Assam, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Bio Veda Technologies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinita Jain  | Director | 04-Jul-2000 | Current |
| Ishaan Jain | Director | 23-Jan-2012 | Current |
Financial Performance and Corporate Structure Insights of Bio Veda Technologies.
Bio Veda Technologies Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 32.26% decrease. The company also saw a substantial fall in profitability, with a 33.08% decrease in profit. The company's net worth moved up by a moderate rise of 3.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bio Veda Technologies?
In 2018, Bio Veda Technologies had a promoter holding of 99.50% and a public holding of 0.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bio Veda Action Research Private LimitedActive 24 years 9 monthsVinita Jain and Ishaan Jain are mutual person
- Bio Veda Botanicals Private LimitedActive 1 year 1 month
Vinita Jain and Ishaan Jain are mutual person
- Biotique Research Laboratories Private LimitedActive 1 year
Vinita Jain and Ishaan Jain are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bio Veda Technologies?
Bio Veda Technologies has a workforce of 0 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bio Veda Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bio Veda Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
